Ensuring transparency: presenting the trade-offs between the research treatment options.
作者信息
Schreiner Mark S
机构信息
a Children's Hospital of Philadelphia and Perelman School of Medicine.
出版信息
Am J Bioeth. 2013;13(12):50-2. doi: 10.1080/15265161.2013.852272.
PMID:24256541
Abstract
摘要
相似文献
1
Ensuring transparency: presenting the trade-offs between the research treatment options.确保透明度：展示研究治疗方案之间的权衡取舍。
Am J Bioeth. 2013;13(12):50-2. doi: 10.1080/15265161.2013.852272.
2
What are reasonably foreseeable risks?哪些是合理可预见的风险？
Am J Bioeth. 2013;13(12):29-30. doi: 10.1080/15265161.2013.849304.
3
The weird divergence of ethics and regulation with regard to informed consent.在知情同意方面，伦理与监管出现了奇怪的分歧。
Am J Bioeth. 2013;13(12):31-3. doi: 10.1080/15265161.2013.849308.
4
Randomization should be disclosed to potential research subjects.随机化过程应向潜在的研究对象公开。
Am J Bioeth. 2013;13(12):35-7. doi: 10.1080/15265161.2013.849307.
5
Risk, respect for persons, and informed consent in comparative effectiveness research.比较效果研究中的风险、对人的尊重与知情同意
Am J Bioeth. 2013;13(12):46-8. doi: 10.1080/15265161.2013.851299.
6
The "research misconception" and the SUPPORT trial: toward evidence-based consensus.“研究误区”与SUPPORT试验：迈向基于证据的共识
Am J Bioeth. 2013;13(12):48-50. doi: 10.1080/15265161.2013.851297.
7
What should be disclosed to research participants?应当向研究参与者披露哪些信息？
Am J Bioeth. 2013;13(12):3-8. doi: 10.1080/15265161.2013.851578.
8
Randomization and the transactional framework for informed consent.随机化与知情同意的交互框架。
Am J Bioeth. 2009 Feb;9(2):16-7. doi: 10.1080/15265160802666297.
9
Understanding randomization: helpful strategies.理解随机化：有用的策略。
Am J Bioeth. 2009 Feb;9(2):14-5. doi: 10.1080/15265160802663245.
10
Randomization can be risky.随机化可能存在风险。
Am J Bioeth. 2009 Feb;9(2):17-8. doi: 10.1080/15265160802668954.
Zotero 插件